184 related articles for article (PubMed ID: 18815281)
21. Epstein-Barr virus latent membrane protein 2A has no growth-altering effects when expressed in differentiating epithelia.
Longan L; Longnecker R
J Gen Virol; 2000 Sep; 81(Pt 9):2245-2252. PubMed ID: 10950982
[TBL] [Abstract][Full Text] [Related]
22. Notch1, Notch2, and Epstein-Barr virus-encoded nuclear antigen 2 signaling differentially affects proliferation and survival of Epstein-Barr virus-infected B cells.
Kohlhof H; Hampel F; Hoffmann R; Burtscher H; Weidle UH; Hölzel M; Eick D; Zimber-Strobl U; Strobl LJ
Blood; 2009 May; 113(22):5506-15. PubMed ID: 19339697
[TBL] [Abstract][Full Text] [Related]
23. Mouse model for acute Epstein-Barr virus infection.
Wirtz T; Weber T; Kracker S; Sommermann T; Rajewsky K; Yasuda T
Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13821-13826. PubMed ID: 27856754
[TBL] [Abstract][Full Text] [Related]
24. LMP2A survival and developmental signals are transmitted through Btk-dependent and Btk-independent pathways.
Merchant M; Longnecker R
Virology; 2001 Dec; 291(1):46-54. PubMed ID: 11878875
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro.
Swanson-Mungerson M; Bultema R; Longnecker R
J Virol; 2006 Jul; 80(14):6764-70. PubMed ID: 16809282
[TBL] [Abstract][Full Text] [Related]
26. Latent membrane protein 2A, a viral B cell receptor homologue, induces CD5+ B-1 cell development.
Ikeda A; Merchant M; Lev L; Longnecker R; Ikeda M
J Immunol; 2004 May; 172(9):5329-37. PubMed ID: 15100272
[TBL] [Abstract][Full Text] [Related]
27. The LMP2A signalosome--a therapeutic target for Epstein-Barr virus latency and associated disease.
Portis T; Cooper L; Dennis P; Longnecker R
Front Biosci; 2002 Feb; 7():d414-26. PubMed ID: 11815296
[TBL] [Abstract][Full Text] [Related]
28. Mouse model of Epstein-Barr virus LMP1- and LMP2A-driven germinal center B-cell lymphoproliferative disease.
Minamitani T; Ma Y; Zhou H; Kida H; Tsai CY; Obana M; Okuzaki D; Fujio Y; Kumanogoh A; Zhao B; Kikutani H; Kieff E; Gewurz BE; Yasui T
Proc Natl Acad Sci U S A; 2017 May; 114(18):4751-4756. PubMed ID: 28351978
[TBL] [Abstract][Full Text] [Related]
29. K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus.
Steinbrück L; Gustems M; Medele S; Schulz TF; Lutter D; Hammerschmidt W
J Virol; 2015 Jul; 89(14):7248-61. PubMed ID: 25948739
[TBL] [Abstract][Full Text] [Related]
30. The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo.
Merchant M; Caldwell RG; Longnecker R
J Virol; 2000 Oct; 74(19):9115-24. PubMed ID: 10982358
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical detection of the Epstein-Barr virus-encoded latent membrane protein 2A in Hodgkin's disease and infectious mononucleosis.
Niedobitek G; Kremmer E; Herbst H; Whitehead L; Dawson CW; Niedobitek E; von Ostau C; Rooney N; Grässer FA; Young LS
Blood; 1997 Aug; 90(4):1664-72. PubMed ID: 9269787
[TBL] [Abstract][Full Text] [Related]
32. Global Proteomic Changes Induced by the Epstein-Barr Virus Oncoproteins Latent Membrane Protein 1 and 2A.
DeKroon RM; Gunawardena HP; Edwards R; Raab-Traub N
mBio; 2018 Jun; 9(3):. PubMed ID: 29921667
[TBL] [Abstract][Full Text] [Related]
33. Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells.
Rancan C; Schirrmann L; Hüls C; Zeidler R; Moosmann A
PLoS Pathog; 2015 Jun; 11(6):e1004906. PubMed ID: 26067064
[TBL] [Abstract][Full Text] [Related]
34. Role of Epstein-Barr virus-encoded latent membrane protein 2A on virus-induced immortalization and virus activation.
Konishi K; Maruo S; Kato H; Takada K
J Gen Virol; 2001 Jun; 82(Pt 6):1451-1456. PubMed ID: 11369890
[TBL] [Abstract][Full Text] [Related]
35. Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection.
Quintanilla-Martinez L; Fend F; Moguel LR; Spilove L; Beaty MW; Kingma DW; Raffeld M; Jaffe ES
Am J Surg Pathol; 1999 Oct; 23(10):1233-40. PubMed ID: 10524524
[TBL] [Abstract][Full Text] [Related]
36. Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2.
Strobl LJ; Höfelmayr H; Marschall G; Brielmeier M; Bornkamm GW; Zimber-Strobl U
J Virol; 2000 Feb; 74(4):1727-35. PubMed ID: 10644343
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus (EBV) LMP2A alters normal transcriptional regulation following B-cell receptor activation.
Portis T; Longnecker R
Virology; 2004 Jan; 318(2):524-33. PubMed ID: 14972521
[TBL] [Abstract][Full Text] [Related]
38. Itchy, a Nedd4 ubiquitin ligase, downregulates latent membrane protein 2A activity in B-cell signaling.
Ikeda A; Caldwell RG; Longnecker R; Ikeda M
J Virol; 2003 May; 77(9):5529-34. PubMed ID: 12692257
[TBL] [Abstract][Full Text] [Related]
39. Role of latent membrane protein 2 isoforms in Epstein-Barr virus latency.
Rechsteiner MP; Bernasconi M; Berger C; Nadal D
Trends Microbiol; 2008 Nov; 16(11):520-7. PubMed ID: 18835714
[TBL] [Abstract][Full Text] [Related]
40. [Current views of the histogenesis and pathogenesis of Hodgkin lymphoma].
Leenman EE
Arkh Patol; 2007; 69(5):7-11. PubMed ID: 18074812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
